title: Gestational trophoblastic disease of the fallopian tube.
abstract: Tubal gestational trophoblastic disease (GTD) was diagnosed in 16 (0.8%) of 2,100 women with GTD managed at the New England Trophoblastic Disease Center. Tubal partial mole, complete mole and choriocarcinoma were present in 5, 5 and 6 patients, respectively. Patients with tubal GTD were not clinically distinguishable from those with traditional tubal pregnancies. While only one patient with tubal mole developed metastases, four patients with tubal choriocarcinoma presented with metastases. All the patients achieved complete, sustained remission.
authors.affiliation: Department of Obstetrics and Gynecology Brigham and Women's Hospital, Boston Massachusetts 02115.
authors.forename: M G
authors.initials: MG
authors.lastname: Muto
authors.forename: J M
authors.initials: JM
authors.lastname: Lage
authors.forename: R S
authors.initials: RS
authors.lastname: Berkowitz
authors.forename: D P
authors.initials: DP
authors.lastname: Goldstein
authors.forename: M R
authors.initials: MR
authors.lastname: Bernstein
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000097:blood; D005185:Fallopian Tube Neoplasms / Q000097:blood / Q000453:epidemiology* / Q000628:therapy; D005260:Female; D006801:Humans; D009511:New England / Q000453:epidemiology; D010298:Parity; D011247:Pregnancy; D012074:Remission Induction; D012307:Risk Factors; D014328:Trophoblastic Neoplasms / Q000097:blood / Q000453:epidemiology* / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D006063:Chorionic Gonadotropin